Amarin Corp Plc (AMRN)

[dukesking]

Tats, I get what you’re saying but I don’t believe it’s as simple as substituting a simple V script for a GV script IMO. One thing that could stop the payers from doing as you suggest is that it would likely require them contacting the doctor for a new prescription for each of the generics components(2 or more)or having an on staff doctor do it. It would also signal an obvious intent to circumvent and infringe on valid patents. I don’t imagine costs difference for the combo would be much higher than the two or more generics combined. I see future value in these Vascepa Plus product(s).